Progressive Pulmonary Fibrosis: Clinical Trials

1 trial for Progressive Pulmonary Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Progressive Pulmonary Fibrosis: new trials by email Literature Review of Progressive Pulmonary Fibrosis trials Research Report on Progressive Pulmonary Fibrosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis
BI 1839100, Placebo - Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Phase 2TerminatedBoehringer Ingelheim852024-08-282026-09-23

Narrower conditions

Idiopathic Pulmonary Fibrosis (1)

Broader conditions

Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Pulmonary Fibrosis (1)  ·  Respiratory Tract Diseases (1)

Sponsors

Boehringer Ingelheim (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Japan (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  New Zealand (1)

NIH funding

2023 (1)